Cargando…

lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer

Although colorectal cancer (CRC) is the third most frequent cause of cancer related death in Europe, clinically relevant biomarkers for therapy guidance and prognosis are insufficiently reliable. Long non-coding RNAs (lncRNAs) are RNAs over 200 nucleotides long that are not translated into proteins...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiele, Jana-Aletta, Hosek, Petr, Kralovcova, Eva, Ostasov, Pavel, Liska, Vaclav, Bruha, Jan, Vycital, Ondrej, Rosendorf, Jachym, Opattova, Alena, Horak, Josef, Kralickova, Milena, Vodicka, Pavel, Pitule, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163783/
https://www.ncbi.nlm.nih.gov/pubmed/30205577
http://dx.doi.org/10.3390/ijms19092672
_version_ 1783359444258652160
author Thiele, Jana-Aletta
Hosek, Petr
Kralovcova, Eva
Ostasov, Pavel
Liska, Vaclav
Bruha, Jan
Vycital, Ondrej
Rosendorf, Jachym
Opattova, Alena
Horak, Josef
Kralickova, Milena
Vodicka, Pavel
Pitule, Pavel
author_facet Thiele, Jana-Aletta
Hosek, Petr
Kralovcova, Eva
Ostasov, Pavel
Liska, Vaclav
Bruha, Jan
Vycital, Ondrej
Rosendorf, Jachym
Opattova, Alena
Horak, Josef
Kralickova, Milena
Vodicka, Pavel
Pitule, Pavel
author_sort Thiele, Jana-Aletta
collection PubMed
description Although colorectal cancer (CRC) is the third most frequent cause of cancer related death in Europe, clinically relevant biomarkers for therapy guidance and prognosis are insufficiently reliable. Long non-coding RNAs (lncRNAs) are RNAs over 200 nucleotides long that are not translated into proteins but can influence biological processes. There is emerging evidence for their involvement in solid cancer as oncogenes, tumour suppressors or regulators of cell proliferation and metastasis development. The goal of this study was to evaluate the prognostic effect of selected lncRNAs in a retrospective study on CRC patients from the Czech Republic. We used a quantitative PCR approach to measure the expression in paired non-malignant and tumour tissue samples of CRC patients of nine lncRNAs previously shown to be involved in cancer progression—ANRIL, CCAT1, GAS5, linc-ROR, MALAT1, MIR155HG, PCAT1, SPRY4-IT1 and TUG1. Associations between expression and expression ratios and clinical characteristics and survival were assessed by using univariable Cox proportional hazards models, Kaplan-Meier estimations with the Gehan-Wilcoxon test, the Mann-Whitney U test, the Kruskal-Wallis test and Spearman’s correlations. A comparison of expression in tumour tissue (TT) and non-malignant mucosa tissue (MT) showed significant upregulation of CCAT1 and linc-ROR in TT (p < 0.001 and p = 0.001, respectively) and downregulation of ANRIL, MIR155HG and MALAT1 (p = 0.001, p = 0.010, p = 0.001, respectively). Linc-ROR was significantly associated with the presence of synchronous metastases (p = 0.033). For individual tissue types, lower MIR155HG expression in TT was correlated with both shorter overall survival (p = 0.008) and shorter disease-free survival (p = 0.040). In MT, expression ratios of CCAT1/ANRIL and CCAT1/MIR155HG were associated with overall survival (p = 0.005 and p = 0.006, respectively). Our results revealed that changes in expression of lncRNAs between MT and TT hold potential to be used as prognostic biomarkers in CRC patients. Moreover, the ratios of CCAT1 to ANRIL and MIR155HG in MT also exhibit potential for prognosis assessment without tumour sampling. Our results also indicate that cancer progression is associated with detrimental system-wide changes in patient tissue, which might govern patient survival even after successful elimination of tumour or cancerous cells.
format Online
Article
Text
id pubmed-6163783
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61637832018-10-10 lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer Thiele, Jana-Aletta Hosek, Petr Kralovcova, Eva Ostasov, Pavel Liska, Vaclav Bruha, Jan Vycital, Ondrej Rosendorf, Jachym Opattova, Alena Horak, Josef Kralickova, Milena Vodicka, Pavel Pitule, Pavel Int J Mol Sci Article Although colorectal cancer (CRC) is the third most frequent cause of cancer related death in Europe, clinically relevant biomarkers for therapy guidance and prognosis are insufficiently reliable. Long non-coding RNAs (lncRNAs) are RNAs over 200 nucleotides long that are not translated into proteins but can influence biological processes. There is emerging evidence for their involvement in solid cancer as oncogenes, tumour suppressors or regulators of cell proliferation and metastasis development. The goal of this study was to evaluate the prognostic effect of selected lncRNAs in a retrospective study on CRC patients from the Czech Republic. We used a quantitative PCR approach to measure the expression in paired non-malignant and tumour tissue samples of CRC patients of nine lncRNAs previously shown to be involved in cancer progression—ANRIL, CCAT1, GAS5, linc-ROR, MALAT1, MIR155HG, PCAT1, SPRY4-IT1 and TUG1. Associations between expression and expression ratios and clinical characteristics and survival were assessed by using univariable Cox proportional hazards models, Kaplan-Meier estimations with the Gehan-Wilcoxon test, the Mann-Whitney U test, the Kruskal-Wallis test and Spearman’s correlations. A comparison of expression in tumour tissue (TT) and non-malignant mucosa tissue (MT) showed significant upregulation of CCAT1 and linc-ROR in TT (p < 0.001 and p = 0.001, respectively) and downregulation of ANRIL, MIR155HG and MALAT1 (p = 0.001, p = 0.010, p = 0.001, respectively). Linc-ROR was significantly associated with the presence of synchronous metastases (p = 0.033). For individual tissue types, lower MIR155HG expression in TT was correlated with both shorter overall survival (p = 0.008) and shorter disease-free survival (p = 0.040). In MT, expression ratios of CCAT1/ANRIL and CCAT1/MIR155HG were associated with overall survival (p = 0.005 and p = 0.006, respectively). Our results revealed that changes in expression of lncRNAs between MT and TT hold potential to be used as prognostic biomarkers in CRC patients. Moreover, the ratios of CCAT1 to ANRIL and MIR155HG in MT also exhibit potential for prognosis assessment without tumour sampling. Our results also indicate that cancer progression is associated with detrimental system-wide changes in patient tissue, which might govern patient survival even after successful elimination of tumour or cancerous cells. MDPI 2018-09-08 /pmc/articles/PMC6163783/ /pubmed/30205577 http://dx.doi.org/10.3390/ijms19092672 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Thiele, Jana-Aletta
Hosek, Petr
Kralovcova, Eva
Ostasov, Pavel
Liska, Vaclav
Bruha, Jan
Vycital, Ondrej
Rosendorf, Jachym
Opattova, Alena
Horak, Josef
Kralickova, Milena
Vodicka, Pavel
Pitule, Pavel
lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer
title lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer
title_full lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer
title_fullStr lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer
title_full_unstemmed lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer
title_short lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer
title_sort lncrnas in non-malignant tissue have prognostic value in colorectal cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163783/
https://www.ncbi.nlm.nih.gov/pubmed/30205577
http://dx.doi.org/10.3390/ijms19092672
work_keys_str_mv AT thielejanaaletta lncrnasinnonmalignanttissuehaveprognosticvalueincolorectalcancer
AT hosekpetr lncrnasinnonmalignanttissuehaveprognosticvalueincolorectalcancer
AT kralovcovaeva lncrnasinnonmalignanttissuehaveprognosticvalueincolorectalcancer
AT ostasovpavel lncrnasinnonmalignanttissuehaveprognosticvalueincolorectalcancer
AT liskavaclav lncrnasinnonmalignanttissuehaveprognosticvalueincolorectalcancer
AT bruhajan lncrnasinnonmalignanttissuehaveprognosticvalueincolorectalcancer
AT vycitalondrej lncrnasinnonmalignanttissuehaveprognosticvalueincolorectalcancer
AT rosendorfjachym lncrnasinnonmalignanttissuehaveprognosticvalueincolorectalcancer
AT opattovaalena lncrnasinnonmalignanttissuehaveprognosticvalueincolorectalcancer
AT horakjosef lncrnasinnonmalignanttissuehaveprognosticvalueincolorectalcancer
AT kralickovamilena lncrnasinnonmalignanttissuehaveprognosticvalueincolorectalcancer
AT vodickapavel lncrnasinnonmalignanttissuehaveprognosticvalueincolorectalcancer
AT pitulepavel lncrnasinnonmalignanttissuehaveprognosticvalueincolorectalcancer